Big Board

Keyword
Content Ideas
Result Content Idea Research
Result Content Idea Research
1 Ebola Vaccine Market Competitive Developmental and Business Overviews to 2026 | Merck and Company, Janssen Pharmaceutica NV, GlaxoSmithKline, and Novavax Inc.
2 J&J’s COVID-19 vaccine enters a new 6,000-person late-stage trial
3 South Africas Aspen Pharmacare, Johnson & Johnson sign COVID-19 vaccine deal
4 Janssen Headlines American Society of Hematology Annual Meeting With More Than 35 Presentations Highlighting Deep, Diverse Oncology Pipeline and Portfolio
5 Alzheimer's Drugs market 2020-2026 Onset of Advanced Technologies to Upsurge the Growth | Pfizer, Inc., Janssen Pharmaceutical, Novartis International AG, Eisai Co. Ltd.
6 Janssen Submits Applications in US and EU Seeking Approval of DARZALEX FASPRO™ (daratumumab and hyaluronidase-fihj)/DARZALEX® (daratumumab) Subcutaneous (SC) Formulation in Combination With Pomalidomide and Dexamethasone for Patients With Relapsed or Refractory Multiple Myeloma
7 Alzheimer's Drugs Market Prospects Pinpoint Higher Traction from Developed Nations during 2020-2026 | Pfizer, Inc., Janssen Pharmaceutical, Novartis International AG, Eisai Co. Ltd.
8 Domperidone Market 2020 Industry Outlook Luckys Pharma, Shreeji Pharma International, Xian Janssen Pharmaceutical
9 Antifungal Agents Market to Register Steady Expansion During (2018-2026)
10 Janssen Submits Application to US FDA for New Indication to Expand Use of XARELTO® (rivaroxaban) in Patients with Peripheral Artery Disease
11 50-State Survey: The Learned Intermediary Doctrine | Butler Snow LLP
12 William Thomas Amick | Obituaries | mebaneenterprise.com
13 Contraceptive Devices Market 2020 to See Strong Investment Opportunity | Top Players – Bayer AG, Pfizer Inc, Janssen Global Services, LLC, Teva Pharmaceutical Industries Ltd
14 Migraine Drugs Market to Record an Exponential CAGR by 2026
15 TREMFYA® (guselkumab) Reduced Fatigue over 52 Weeks in Adult Patients with Psoriatic Arthritis in Two Phase 3 Clinical Trials
16 Here is why Halozyme Therapeutics Inc. (HALO) recent weekly performance of 17.65% shouldn’t bother you at All
17 Uroflowmetry Device Market Development And Trends Forecasts 2020-2026:Ono Pharmaceutical Co., Ltd. (Japan), Astellas Pharma, Inc. (Japan), Ortho-McNeil-Janssen Pharmaceuticals, Inc. (USA)
18 Injectables Firms Expand Capacity
19 Contraceptives Market Sees a Downtrend in 2020 as COVID-19 Suspends Production 2025
20 Global Transdermal Patches Market Future Scope Including Top Players –Bayer AG, ANI Pharmaceuticals Inc., Novartis AG, Janssen Pharmaceuticals Inc., Antares Pharma Inc., Aneva Drug Delivery Systems, Abbott Laboratories, Medipatch, Inc
21 MediPharm Labs Appoints Former President of Janssen Inc., one of the Janssen Pharmaceutical Companies of Johnson & Johnson, to Board of Directors
22 Fertility Drugs Market Report 2020: Industry Analysis, Trends And Forecast By 2023 | Leading Players
23 Janssen Pharmaceutical Companies Expands R&D at San Francisco, California Campus
24 Horizon Therapeutics plc and Halozyme Therapeutics, Inc. Enter Global Collaboration and License Agreement for ENHANZE® Technology
25 TRACON Pharmaceuticals
26 Johnson & Johnson to Acquire Momenta Pharmaceuticals, Inc., Expanding Janssen's Leadership in Novel Treatments for Autoimmune Diseases
27 Covid-19 vaccine update: Pfizer announces 95% efficacy, Spain authorises phase 3 trial of Janssen’s...
28 Ascendis Pharma A/S Appoints Dr. Mark A. Bach as Senior Vice President of Clinical Development and Medical Affairs for Endocrinology Rare Diseases
29 GLOBAL NEUROLOGICAL BIOMARKERS MARKET Remarkable Growth By 2026||BANYAN BIOMARKERS, INC; Merck KGaA,; F. Hoffmann-La Roche Ltd; Janssen Global Services, LLC,; Charles River; Advanced Brain Monitoring, Inc.; Neurosteer
30 Janssen Announces Completion of Acquisition of Investigational Bermekimab from XBiotech Inc.
31 Prophylactic Human Vaccine Market Size, Emerging Evolution and Opportunities Till 2026 | GlaxoSmithKline Plc., Merck & Co., Inc., Pfizer Inc., Janssen Pharmaceuticals, Inc., Altimmune, Inc.
32 Ligand Announces Clinical and Regulatory Progress by Multiple Partners with OmniAb® Antibodies
33 Janssen to Present Key Data from Across Its Expansive Oncology Portfolio at ESMO 2020 Virtual Congress
34 Alcohol Ethoxylates Market Analysis and Growth Forecast by Applications, Sales, Size, Types and Competitors by 2020-2026
35 Tryon Medical Partners, Javara chosen for second Covid-19 vaccine trial
36 Janssen Highlights Innovative Oncology Portfolio and Pipeline of Oral, Biologic and Cell Therapies Through ASCO20 Virtual Scientific Program
37 Catchup Capsule: Key APAC Insights You Need To Read
38 Global N Methyl 2 Pyrrolidone Market Overview, Cost Structure Analysis, Growth Opportunities and Forecast to 2026
39 MeiraGTx Announces Investigational Gene Therapy Continues to Demonstrate Statistically Significant Improvement in Vision in Patients with X-Linked Retinitis Pigmentosa One Year After Treatment
40 Global Pelvic Inflammatory Disease (PID) Market Outlook, Development Factors, Latest Opportunities And Forecast 2027||Sanofi, Merck & Co., Inc, Mylan NV, Teva Pharmaceutical Industries Ltd, Bristol Myers Squibb Company
41 Wood Preservative Chemicals and Coatings Active Ingredient Market Competitive Research And Precise Outlook 2020-2027
42 COVID-19 Update: Sinusitis Treatment Drugs Market Competitive Intelligence Analysis 2020-2025| Abbott Laboratories, Inc., Bayer AG, GlaxoSmithkline, Plc. Janssen Pharmaceuticals, Inc., Pfizer, Inc., Sanofi SA.
43 Genmab to Present at Jefferies Virtual London Healthcare Conference
44 Gastrointestinal Drugs Market Forecast to 2027
45 MeiraGTx Reports Third Quarter 2020 Financial Results Nasdaq:MGTX
46 Impact of COVID-19 on Contraceptive Rings Market Share, Size and Demand, Concludes Fact.MR
47 BE ties up with Janssen Pharmaceutica NV for COVID-19 vaccine production
48 Global Ibrutinib Market 2020 By Advancements, Challenges, Top Manufacturers, Growth, Applications & Forecast till 2027
49 Five Companies Edging Closer to SARS-CoV-2 Vaccine Emergency Use Authorization
50 Other news to note for Nov. 17, 2020 | 2020-11-17
51 Janssen Expands Research & Development Presence with Major Investment in South San Francisco
52 Johnson // Becker, PLLC Files Elmiron Lawsuits Against Janssen Pharmaceutical For Elmiron Associated Retinal Maculopathy
53 Other news to note for Nov. 16, 2020 | 2020-11-16
54 Arcturus Therapeutics Announces Positive Interim ARCT-021 (LUNAR-COV19) Phase 1/2 Study Results for Both Single Shot and Prime-boost Regimens, and Up to $220 Million in Additional Financial Commitments from Singapore | Vaccines | News Channels
55 Global Infectious Disease Therapeutics Market 2020 Industry Growth, size, Manufacturers, and Forecast Research Report to 2026
56 Vaccine tested at Emory highly effective in preventing COVID-19, study says
57 Arcturus Therapeutics Announces Third Quarter 2020 Financial Results and Positive Clinical Updates for ARCT-810 Phase I Study and Additional ARCT-021 Interim Data
58 Aleafia Health Approved by Janssen Pharmaceuticals to Administer Antidepressant SPRAVATO®
59 Genmab Announces Financial Results for the First Nine Months of 2020
60 Johnson & Johnson Completes Acquisition of Momenta Pharmaceuticals, Inc.
61 Active Pharmaceutical Ingredients Market Report 2020 by Key Players, Types, Applications, Countries, Market Size, Forecast to 2026 (Based on 2020 COVID-19 Worldwide Spread)
62 Global Psychedelic Drugs Market to Witness Huge Growth by Worldwide| Global Current Trade Size And Future Prospective
63 Warp Speed chief visits Emory, urges participation in COVID vaccine trials
64 Novel Coronavirus (COVID-19) Vaccine Market Research Report- Opportunities & Challenges With Totally Different Segments, Forecast- 2026
65 Capital Increase in Genmab as a Result of Employee Warrant Exercise
66 Governor Cuomo Announces Insurance Fraud Action Against Johnson & Johnson for Leading Role in the Opioid Crisis
67 Infectious Disease Therapeutics Market Trends Worldwide and Foresight Research Report to 2026
68 Enigma Biomedical Group Signs Agreement to License Novel Neuro Imaging Biomarkers From Janssen
69 Migraine Drugs Market 2020: Insights By Revenue, Upcoming Trends And Worldwide Players Forecast Till 2026
70 Janssen Pharmaceuticals Collaborates with Alveo on Rapid At-Home COVID-19 Test
71 Comprehensive Report on Alzheimer's Therapeutics Market 2020 | Size, Growth, Demand, Opportunities & Forecast To 2026 | Pfizer, Merck &, Novartis AG, Eisai, H. Lundbeck A/S
72 Johnson & Johnson Announces Agreement with US Government for 100 Million Doses of Investigational COVID-19 Vaccine
73 Actelion (a Janssen Pharmaceutical company of J&J) announce positive final results of new study
74 Rising Number of Cases Reinforces the Need for Comprehensive Diagnostics
75 This Could be Game-Changing News for Psilocybin’s Treatment of Mental Health
76 Vitally Important COVID-19 Test Kit Market Could Exceed $15 Billion This Year Alone
77 Alveo Technologies Announces Research Collaboration with Janssen Pharmaceuticals, Inc. to Advance At-Home Testing Platform for Viral Infectious Diseases
78 Janssen Pharmaceutical Cos. (J&J) and BARDA
79 J&J sees 'tremendous opportunity' in robotics as it unveils Ottava details
80 J&J's Janssen Speeds Up Planned Launch of COVID-19 Vaccine Trial
81 Janssen Pharmaceutical Cos. (Johnson & Johnson)
82 Vaccines Market 2020 Market Segment, Drivers, Trends, Forecast to 2025
83 Janssen Presents Findings from Global, Multi-Centre Trial Examining Amivantamab in Combination with Lazertinib in Patients with EGFR-Mutated Non-Small Cell Lung Cancer
84 Global Soft Tissue Repair Equipment Market Report: Production, Revenue, Price Trend by Types & Market Analysis by Application
85 GRAM Partners with Johnson & Johnson on Manufacturing in Fight Against COVID-19
86 JNJ: 3 Pharmaceutical Stocks to Buy Now, Before a COVID-19 Vaccine is Created
87 Janssen to Discontinue Pimodivir Influenza Development Program
88 Janssen to Acquire Investigational Bermekimab from XBiotech
89 Janssen Highlights Impact of Multiple Sclerosis-Related Fatigue with Real-World Study Data Presentation at MSVirtual2020 and Global Patient Survey
90 JNJ: 3 Top Pharmaceutical Stocks That Pay Dividends
91 Johnson & Johnson Announces European Commission Approval of Agreement to Supply 200 Million Doses of Janssen's COVID-19 Vaccine Candidate
92 Lava Therapeutics Announces Collaboration with Janssen to Develop Bi-specific Gamma-Delta T-cell Engager Therapeutics
93 Janssen Announces Phase 1 Results for Bispecific Antibody Amivantamab in the Treatment of Patients with Advanced Non-Small Cell Lung Cancer Harbouring Exon 20 Insertion Mutations
94 Fourth large-scale COVID-19 vaccine trial begins in the United States
95 Vifor Pharma Enters Into Commercial Collaboration in the US with Janssen
96 Janssen Pharmaceutical acquires rights to XBiotech’s bermekimab compound
97 Janssen Announces US FDA Approval of SPRAVATO® (esketamine) CIII Nasal Spray to Treat Depressive Symptoms in Adults with Major Depressive Disorder with Acute Suicidal Ideation or Behavior
98 J&J collaboration to expand COVID-19 vaccine candidate manufacturing
99 Lava Therapeutics and Janssen Biotech to Collaborate on Cancer Treatment Research
100 Janssen Announces US FDA Breakthrough Therapy Designation Granted for JNJ-6372 for the Treatment of Non-Small Cell Lung Cancer | Antibodies | News Channels